A cheap FTSE 250 share I’d love to own forever!

This brilliant FTSE 350 stock’s currently on sale! Here’s why Royston Wild thinks it’s a brilliant buy to consider for growth AND income investors.

| More on:
Young black colleagues high-fiving each other at work

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

No one definitively knows what’s around the corner. Unexpected events mean that even the most robust FTSE 100 and FTSE 250 stocks may suddenly turn into basket cases over a number of years.

The best we can do as investors is to research as much as possible before buying, and then to quickly react if/when things change.

As things stand, I believe this UK blue-chip share will deliver impressive shareholder returns. It’s why I hold it in my Stocks and Shares ISA right now.

Here’s why I believe Spire Healthcare (LSE:SPI) is a top pick for me, especially at current prices.

Soaring sales

Spire Healthcare's share price performance since 2019.
Spire Healthcare’s share price performance since 2019. Created with TradingView

Years of underinvestment in the National Health Service (NHS) have decimated service levels and pushed waiting lists to record highs. According to researcher British Social Attitudes, fewer than one in four Britons are now satisfied with the service. This is the lowest figure since records began 41 years ago.

It’s no coincidence that, at the same time, demand for private healthcare — either through self-pay or private medical insurance — is rocketing. FTSE 250-quoted Spire is one big winner from this boom.

It’s one of the UK’s largest independent healthcare groups, with 39 hospitals in its portfolio and dozens more clinics and medical centres. Last year, it saw revenues soar 13.1% from 2022 levels, while operating profit jumped 32.3% year on year.

Cheap as chips

Changes to NHS funding could significantly curtail Spire’s profits potential. But as things stand, future governments (regardless of party) are still likely to struggle to improve the service as the UK’s rapidly ageing population balloons. So demand for private healthcare providers like this should remain robust.

Spire's revenues, earnings and dividend forecasts to 2026,
Source: Digital Look

This is why, despite the threat of medical staff shortages, City analysts expect Spire’s earnings to keep soaring through to 2026 at least. This can be seen in the graphic above.

These predictions also leave Spire shares trading on a price-to-earnings growth (PEG) ratio below the value watermark of 1.

Dividend growth too

Spire is more than just an exciting value and growth stock too. Dividends here have rebounded strongly since the end of the Covid-19 crisis. And City analysts expect them to continue rapidly rising.

On the downside, the healthcare giant doesn’t offer especially large dividend yields at current prices of 231.5p per share. For 2024, the reading comes in at just 1.1%.

But this isn’t a dealbreaker to me. As a long-term investor, I’m also seeking companies that can grow the dividend over time to offset the impact of inflation. And Spire could be in great shape to grow cash rewards rapidly for the reasons I mention.

Indeed, its dividend yield marches to an improved 2% for 2026, almost double this year’s level.

I believe Spire could be one of the best all-rounders on the FTSE 250 today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has positions in Spire Healthcare Group Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

2 FTSE 100 high dividend shares to consider in May

I'm building a list of the best FTSE 100 income shares to buy this month. Here are two I'm expecting…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: Share Advisor’s latest lower-risk, higher-yield recommendation [PREMIUM PICKS]

Ice ideas will usually offer a steadier flow of income and is likely to be a slower-moving but more stable…

Read more »

Investing Articles

Here’s how I’d target passive income from FTSE 250 stocks right now

Dividend stocks aren't the only ones we can use to try to build up some long-term income. No, I like…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

If I put £10k in this FTSE 100 stock, it could pay me a £1,800 second income over the next 2 years

A FTSE 100 stock is carrying a mammoth 10% dividend yield and this writer reckons it could contribute towards an…

Read more »

Investing Articles

2 UK shares I’d sell in May… if I owned them

Stephen Wright would be willing to part with a couple of UK shares – but only because others look like…

Read more »

Investing Articles

2 FTSE 250 shares investors should consider for a £1,260 passive income in 2024

Investing a lump sum in these FTSE 250 shares could yield a four-figure dividend income this year. Are they too…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

This FTSE share has grown its decade annually for over 30 years. Can it continue?

Christopher Ruane looks at a FTSE 100 share that has raised its dividend annually for decades. He likes the business,…

Read more »

Elevated view over city of London skyline
Investing Articles

Few UK shares grew their dividend by 90% in 4 years. This one did!

Among UK shares, few have the recent track record of annual dividend increases to match this one. Our writer likes…

Read more »